268 related articles for article (PubMed ID: 22413953)
1. Targeting angiogenesis for the treatment of prostate cancer.
Antonarakis ES; Carducci MA
Expert Opin Ther Targets; 2012 Apr; 16(4):365-76. PubMed ID: 22413953
[TBL] [Abstract][Full Text] [Related]
2. From bevacizumab to tasquinimod: angiogenesis as a therapeutic target in prostate cancer.
Schweizer MT; Carducci MA
Cancer J; 2013; 19(1):99-106. PubMed ID: 23337763
[TBL] [Abstract][Full Text] [Related]
3. Targeting Angiogenesis in Prostate Cancer.
Melegh Z; Oltean S
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151317
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis inhibitors in the treatment of prostate cancer.
Adesunloye BA; Karzai FH; Dahut WL
Chem Immunol Allergy; 2014; 99():197-215. PubMed ID: 24217611
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab treatment of prostate cancer.
Small AC; Oh WK
Expert Opin Biol Ther; 2012 Sep; 12(9):1241-9. PubMed ID: 22775507
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and anti-angiogenic therapy in prostate cancer.
Mukherji D; Temraz S; Wehbe D; Shamseddine A
Crit Rev Oncol Hematol; 2013 Aug; 87(2):122-31. PubMed ID: 23375349
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis inhibitors in the treatment of prostate cancer.
Kluetz PG; Figg WD; Dahut WL
Expert Opin Pharmacother; 2010 Feb; 11(2):233-47. PubMed ID: 20088745
[TBL] [Abstract][Full Text] [Related]
8. Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer.
Mavrou A; Brakspear K; Hamdollah-Zadeh M; Damodaran G; Babaei-Jadidi R; Oxley J; Gillatt DA; Ladomery MR; Harper SJ; Bates DO; Oltean S
Oncogene; 2015 Aug; 34(33):4311-9. PubMed ID: 25381816
[TBL] [Abstract][Full Text] [Related]
9. Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Montico F; Kido LA; Hetzl AC; Cagnon VH
Prostate; 2015 Apr; 75(5):484-99. PubMed ID: 25521760
[TBL] [Abstract][Full Text] [Related]
10. Emerging angiogenesis inhibitors for non-small cell lung cancer.
Malapelle U; Rossi A
Expert Opin Emerg Drugs; 2019 Jun; 24(2):71-81. PubMed ID: 31092048
[No Abstract] [Full Text] [Related]
11. Targeting VEGF in lung cancer.
Das M; Wakelee H
Expert Opin Ther Targets; 2012 Apr; 16(4):395-406. PubMed ID: 22439677
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
Gotink KJ; Verheul HM
Angiogenesis; 2010 Mar; 13(1):1-14. PubMed ID: 20012482
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets.
Ioannidou E; Moschetta M; Shah S; Parker JS; Ozturk MA; Pappas-Gogos G; Sheriff M; Rassy E; Boussios S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576107
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic therapy: concept to clinic.
Young RJ; Reed MW
Microcirculation; 2012 Feb; 19(2):115-25. PubMed ID: 22078005
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis inhibition in the treatment of prostate cancer.
Madan RA; Dahut WL
Anticancer Agents Med Chem; 2009 Dec; 9(10):1070-8. PubMed ID: 19719453
[TBL] [Abstract][Full Text] [Related]
16. Is VEGF a predictive biomarker to anti-angiogenic therapy?
Otrock ZK; Hatoum HA; Musallam KM; Awada AH; Shamseddine AI
Crit Rev Oncol Hematol; 2011 Aug; 79(2):103-11. PubMed ID: 20724177
[TBL] [Abstract][Full Text] [Related]
17. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
18. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
Lopes-Coelho F; Martins F; Pereira SA; Serpa J
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916438
[TBL] [Abstract][Full Text] [Related]
19. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
20. [Anti angiogenesis].
Akaza H; Nakagawa M; Tsuruo T; Saijo N; Sone S; Yamamoto N; Kakeji Y; Nakamura S; Kurebayashi J; Isonishi S; Ohashi Y; Blackledge G; Carmichael J
Gan To Kagaku Ryoho; 2004 Apr; 31(4):647-55. PubMed ID: 15114718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
